NCT02247687: Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) |
|
|
| Terminated | 3 | 4 | Europe | Protease inhibitor, Prezista® / Norvir®, Isentress® (raltegravir), Counseling arm | ANRS, Emerging Infectious Diseases, Janssen-Cilag Ltd. | HIV-1 Infection, Treatment Resistant Disorders, Viremia | 09/15 | 09/15 | | |
